Pituitary Society Guidance: Pituitary Disease Management ...
Function of the Pituitary - capanet.org€¦ · Common Pituitary Disorders David Doriguzzi, PA-C...
Transcript of Function of the Pituitary - capanet.org€¦ · Common Pituitary Disorders David Doriguzzi, PA-C...
Dav
id D
orig
uzzi
, PA
-C
Com
mon
Pitu
itary
Dis
ord
ers
Func
tion
of th
e P
ituita
ry•
Gro
wth
•B
lood
pre
ssur
e
•U
terin
e co
ntra
ctio
ns d
urin
g c
hild
birt
h
•B
reas
t milk
pro
duc
tion
•S
ex o
rgan
func
tions
•Th
yroi
d g
land
func
tion
•W
ater
and
osm
olar
ity re
gul
atio
n in
the
bod
y
•Te
mp
erat
ure
reg
ulat
ion
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
one
(GH
)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL
)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
one
(GH
)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•T
hyr
oid
Sti
mu
lati
ng
Ho
rmo
ne
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
one
(GH
)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•F
olli
cle
Sti
mu
lati
ng
Ho
rmo
ne
(FS
H)
•L
euti
niz
ing
Ho
rmo
ne
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
one
(GH
)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
no
cort
ico
tro
pic
Ho
rmo
ne
(AC
TH
)
•G
row
th H
orm
one
(GH
)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
on
e (G
H)
•E
ndor
phi
ns
Func
tion
of th
e P
ituita
ry•
Ant
erio
r P
ituita
ry
•P
rola
ctin
(P
RL)
•Th
yroi
d S
timul
atin
g H
orm
one
(TS
H)
•Fo
llicl
e S
timul
atin
g H
orm
one
(FS
H)
•Le
utin
izin
g H
orm
one
(LH
)
•A
dre
noco
rtic
otro
pic
Hor
mon
e (A
CTH
)
•G
row
th H
orm
one
(GH
)
•E
nd
orp
hin
s
Func
tion
of th
e P
ituita
ry
•P
oste
rior
Pitu
itary
•O
xyto
cin
•A
ntid
iure
tic H
orm
one
(AD
H)
•R
ule
of
"To
o's
"
•To
o m
uch
•To
o lit
tle
•To
o-m
or (
tum
or)
Whe
n Th
ing
s G
o W
rong
Pitu
itary
Mas
s•
Mos
t pitu
itary
mas
ses
are
ben
ign
tum
ors
that
may
or
may
not
sec
rete
exc
essi
ve
amou
nt o
f a p
artic
ular
hor
mon
e
•P
ituita
ry m
asse
s co
mp
rise
10%
of a
ll in
trac
rani
al n
eop
lasm
s (1
)
•U
p to
25%
of t
he g
ener
al p
opul
atio
n ha
ve
a sm
all p
ituita
ry m
ass
•M
ost a
re a
sym
pto
mat
ic
Pitu
itary
Mas
s
•M
ost s
igni
fican
t phy
sica
l co
mpl
icat
ion
is p
ress
ure
on
the
optic
chi
asm
•T
his
resu
lts in
impa
irmen
t of
perip
hera
l vis
ion
Pitu
itary
Mas
s
•M
icro
aden
oma
- <
1 cm
dia
met
er•
Mac
road
enom
a -
> 1
cm
dia
met
er
•Tr
ansp
heno
idal
ssur
gica
l res
ectio
n is
in
dica
ted
if tu
mor
is la
rge
enou
gh to
hav
e ob
stru
ctiv
e ef
fect
s (2
)
Hyp
erp
rola
ctin
emia
•T
he m
ajor
ity o
f clin
ical
ly id
entif
ied
pitu
itary
ade
nom
as
are
prol
actin
omas
. (3)
•T
he m
ost c
omm
on c
ause
of h
yper
prol
actin
emia
is p
resc
riptio
n m
edic
atio
n us
e. (4
)
•D
rug
s w
ith d
opam
ine
anta
gon
istic
act
ion
blo
ck d
opam
ine'
s su
pp
ress
ion
of
pro
lact
in
•R
egla
n, A
nti-p
sych
otic
s, R
ozer
em
•A
lso
can
be tr
igge
red
by C
RF,
Hyp
othy
roid
ism
, Sar
coid
osis
, or
idio
path
ic h
ypot
hala
mic
-pitu
itary
dys
regu
latio
n
Hyp
erp
rola
ctin
emia
•S
ymp
tom
s
•G
alac
torr
hea
•B
reas
t enl
arg
emen
t
•B
reas
t ten
der
ness
•A
novu
lato
ry a
men
orrh
ea
•Ir
reg
ular
per
iod
s
•D
ecre
ased
lib
ido
•In
men
, can
cau
se d
ecre
ased
lib
ido,
ere
ctile
dys
func
tion,
and
infe
rtili
ty
Wor
kup
and
Dia
gno
sis
•B
lood
wor
k sh
ows
elev
ated
pro
lact
in le
vels
•E
stra
dio
l, FS
H, L
H, P
rog
este
rone
, and
Te
stos
tero
ne s
houl
d b
e ch
ecke
d to
rul
e ou
t oth
er h
orm
onal
imb
alan
ce
•K
idne
y an
d li
ver
func
tions
sho
uld
be
chec
ked
to r
ule
out r
enal
and
hep
atic
et
iolo
gie
s
•S
erum
pre
gna
ncy
test
sho
uld
be
per
form
ed
Wor
kup
and
Dia
gno
sis
•P
ituita
ry M
RI c
an id
entif
y a
tum
or a
nd
pro
vid
e a
bas
elin
e m
easu
rem
ent o
f si
ze
•C
T sc
an is
not
the
stud
y of
cho
ice
•Vi
sual
fiel
d te
stin
g s
houl
d b
e p
erfo
rmed
dur
ing
phy
sica
l exa
m
Trea
tmen
t•
Cau
sativ
e m
edic
atio
ns s
houl
d b
e w
ithd
raw
n (if
pos
sib
le)
•D
opam
ine
agon
ists
pro
vid
e sy
mp
tom
atic
relie
f and
can
shr
ink
tum
ors
(5)
•B
rom
ocrip
tine
is d
osed
nig
htly
sta
rtin
g a
t 2.5
mg
QH
S
•C
aber
gol
ine
is d
osed
twic
e w
eekl
y (0
.25
- 0.
5 m
g B
IW)
and
tend
s to
be
mor
e ef
fect
ive
•Fo
llow
up M
RIs
allo
w m
onito
ring
of t
umor
reg
ress
ion
•S
urg
ical
rese
ctio
n m
ay b
e ne
cess
ary
for
mac
road
enom
as w
ith
sig
nific
ant c
omp
ress
ive
sym
pto
ms
Trea
tmen
t•
Ther
apy
shou
ld p
ersi
st fo
r 12
mon
ths
and
then
with
dra
wn
•If
pro
lact
in le
vels
ris
e an
d s
ymp
tom
s re
turn
, the
rap
y is
re
star
ted
•A
fter
24 m
ore
mon
ths,
ther
apy
is w
ithd
raw
n ag
ain
•If
sym
pto
ms
retu
rn, t
hera
py
is c
ontin
ued
for
life
(6)
•D
eXA
sca
n is
war
rant
ed, s
ince
pro
long
ed h
ypog
onad
ism
as
soci
ated
with
hyp
erp
rola
ctin
emia
can
lead
to o
steo
por
osis
.
Gro
wth
Hor
mon
e D
efic
ienc
y•
In c
hild
ren,
gro
wth
hor
mon
e is
res
pons
ible
for
the
man
y pr
oces
ses
in n
orm
al g
row
th in
clud
ing
leng
then
ing
of lo
ng
bone
s
•In
adu
lts, g
row
th h
orm
one
leve
ls n
atur
ally
dec
line
sign
ifica
ntly
, but
is s
till p
rese
nt•
Fun
ctio
ns in
mai
nten
ance
of m
uscl
e m
ass,
reg
ulat
ion
of m
uscl
e m
ass,
and
met
abol
ic r
ates
Gro
wth
Hor
mon
e D
efic
ienc
y•
Def
icie
ncy
of g
row
th h
orm
one
in c
hild
ren
resu
lts in
sh
ort s
tatu
re a
nd r
eten
tion
of c
hild
-like
phy
sica
l fe
atur
es•
“Sho
rt S
tatu
re”
is d
efin
ed a
s he
ight
that
is 2
sta
ndar
d de
viat
ions
be
low
the
aver
age
heig
ht fo
r a
pers
on’s
age
and
gen
der.
(7)
•P
ituita
ry d
war
fism
is n
ot th
e sa
me
as a
chon
drop
lasi
a•
Pitu
itary
dw
arfis
m r
esul
ts in
pro
port
iona
te g
row
th r
etar
datio
n.
Gro
wth
Hor
mon
e D
efic
ienc
yG
row
th H
orm
one
Def
icie
ncy
•G
H D
efic
ienc
y in
adu
lts le
ads
to n
on-s
peci
fic s
ympt
oms:
•Fa
tigue
/dec
reas
ed e
nerg
y
•W
eig
ht g
ain/
diff
icul
ty lo
sing
wei
ght
•D
ecre
ased
stre
ngth
•E
mot
iona
l lab
ility
•D
ecre
ased
lib
ido
•A
sym
pto
mat
ic (8
)
•G
row
th H
orm
one
and
IGF
-1 le
vels
are
low
in c
hild
ren
with
GH
def
icie
ncy.
•A
han
d X
-ray
for
Bon
e A
ge d
eter
min
atio
n he
lps
pred
ict
resp
onsi
vene
ss to
ther
apy.
•In
sulin
tole
ranc
e te
st is
the
stan
dard
test
in a
dults
with
pr
esum
ed G
H d
efic
ienc
y
GG
Gro
wth
Hor
mon
ean
dIG
F-1
leve
lsar
elo
win
child
ren
Wor
kup
and
Dia
gno
sis
Gro
wth
Hor
mon
e D
efic
ienc
y•
Trea
tmen
t is
grow
th h
orm
one
repl
acem
ent
•G
iven
as
a da
ily in
ject
ion
•T
hera
py is
nor
mal
ly in
itiat
ed a
nd m
onito
red
by a
n en
docr
inol
ogis
t
•A
vaila
ble
med
icat
ions
incl
ude
•N
utro
pin
•H
umat
rope
•G
enot
ropi
n•
Nor
ditr
opin
•Te
v-Tr
opin
•S
aize
n
Gro
wth
Hor
mon
e D
efic
ienc
y•
Gro
wth
hor
mon
e an
d IG
F-1
mus
t be
mon
itore
d pe
riodi
cally
th
roug
hout
trea
tmen
t•I
nsuf
ficie
nt le
vels
will
res
ult i
n no
impr
ovem
ent,
exce
ssiv
e le
vels
ca
n in
crea
se th
e po
ssib
ility
of s
ide
effe
cts
incl
udin
g S
lippe
d C
apita
l Fem
oral
Epi
phys
is, P
seud
otum
or C
ereb
ri, a
nd s
ome
canc
ers
•In
chi
ldre
n, tr
eatm
ent c
ontin
ues
until
epi
phys
es c
lose
and
gr
owth
sto
ps.
Acr
omeg
aly
•C
ause
d by
exc
essi
vely
hig
h G
row
th H
orm
one
•U
sual
ly c
ause
d by
a G
H-p
rodu
cing
pitu
itary
ade
nom
a
•P
hysi
cal m
anife
stat
ions
usu
ally
dev
elop
slo
wly
in 3
0s a
nd
40s,
so
the
dise
ase
can
be h
ard
to d
iagn
ose
in it
s ea
rly
stag
es
•C
an c
ause
gig
antis
m, b
ut u
sual
ly c
ause
s ch
arac
teris
tical
ly la
rge
hand
s, b
row
rid
ge, a
nd s
quar
e ja
w
Acr
omeg
aly
Acr
omeg
aly
•D
iagn
osis
is m
ade
by c
heck
ing
GH
leve
ls o
ne h
our
afte
r 1
hour
glu
cose
tole
ranc
e te
st
•G
H le
vels
>1
ug/L
mee
ts d
iagn
ostic
crit
eria
(no
rmal
ly G
H w
ould
be
supp
ress
ed b
elow
1 u
g/L)
•C
ompl
icat
ions
incl
ude
•H
eada
che
•V
isua
l Dis
turb
ance
s fr
om tu
mor
•C
ardi
omeg
aly
& H
eart
Fai
lure
•H
yper
tens
ion
•A
rthr
itis
•D
iabe
tes
•K
idne
y F
ailu
re
Acr
omeg
aly
•Tr
eatm
ent u
sual
ly c
onsi
sts
of s
urgi
cal r
emov
al o
f th
e tu
mor
•M
edic
atio
n is
use
d th
erea
fter
if G
H le
vels
rem
ain
elev
ated
from
res
idua
l tis
sue
•O
ctre
otid
e (S
ando
stat
in)
- in
ject
ed e
very
oth
er w
eek
•La
nreo
tide
(Som
atul
ine)
- in
ject
ed e
very
oth
er w
eek
•D
opam
ine
agon
ists
(B
rom
ocrip
tine
or C
aber
golin
e) (9
)
•R
adia
tion
to th
e pi
tuita
ry c
an b
e us
ed in
pat
ient
s w
ho a
re n
ot c
andi
date
s fo
r su
rger
y
Cus
hing
's D
isea
se•
The
pitu
itary
ove
r-se
cret
es A
CT
H, p
rom
ptin
g th
e ad
rena
ls to
ove
r-se
cret
e co
rtis
ol. (
10)
•M
ost c
omm
only
(80
%)
caus
ed b
y an
ade
nom
a in
the
ante
rior
pitu
itary
.
•C
ause
s cl
assi
c C
ushi
ng S
yndr
ome
sym
ptom
s:
•W
eig
ht g
ain
•M
oon
face
•B
uffa
lo h
ump
•A
bd
omin
al s
tria
e
•H
irsut
ism
•A
men
orrh
ea
•Th
inni
ng s
kin
•H
yper
tens
ion
(11)
Cus
hing
's D
isea
se
Wor
kup
•24
-hou
r ur
ine
cort
isol
leve
l can
be
used
for
dete
rmin
atio
n of
Cus
hing
Syn
drom
e.
•D
exam
etha
sone
Sup
pres
sion
Tes
t ass
ists
in
dete
rmin
atio
n of
the
etio
logy
.
•In
Cus
hing
's D
isea
se, A
CT
H le
vels
rem
ain
elev
ated
eve
n af
ter
expo
sure
to h
igh-
dose
dex
amet
haso
ne. (
12)
•P
ituita
ry M
RI m
ay v
isua
lize
an a
deno
ma.
Cus
hing
's D
isea
se
Trea
tmen
t
•Tr
eatm
ent u
sual
ly in
volv
es tr
ansp
heno
idal
re
sect
ion
of th
e tu
mor
. (13
)
Ref
eren
ces
1.D
aly
AF,
Rix
hon
M, A
dam
C e
t al.
Hig
h pr
eval
ence
of p
ituita
ry a
deno
mas
: a c
ross
-sec
tiona
l stu
dy in
th
e pr
ovin
ce o
f Lie
ge, B
elgi
um. J
Clin
End
ocrin
ol M
etab
. 200
6 D
ec;9
1(12
):47
69-7
5.2.
Wu,
J. T
rans
sphe
noid
al p
ituita
ry m
acro
aden
omas
res
ectio
n gu
ided
by
Pol
eSta
r N
20 lo
w-f
ield
in
trao
pera
tive
mag
netic
res
onan
ce im
agin
g: c
ompa
rison
with
ear
ly p
osto
pera
tive
high
-fie
ld m
agne
tic
reso
nanc
e im
agin
g. N
euro
surg
ery.
200
9; 6
5(1)
:63-
70; d
iscu
ssio
n 70
-13.
Fer
nand
ezA
, et a
l. P
reva
lenc
e of
pitu
itary
ade
nom
as: a
com
mun
ity-b
ased
, cro
ss-s
ectio
nal s
tudy
in
Ban
bury
(O
xfor
dshi
re, U
K).
Clin
End
ocrin
ol (
Oxf
). 2
010;
72(
3):3
77-8
24.
Dav
ies,
PH
. Dru
g-re
late
d hy
perp
rola
ctin
aem
ia. A
dver
se D
rug
Rea
ct T
oxic
ol R
ev.
1997
; 16(
2):8
3-94
5.C
olao
A, D
i Sar
no A
, Gue
rra
E, D
e Le
o M
, Men
tone
A, L
omba
rdi G
(A
pril
2006
). "
Dru
g in
sigh
t: C
aber
golin
e an
d br
omoc
riptin
e in
the
trea
tmen
t of h
yper
prol
actin
emia
in m
en a
nd w
omen
". N
at C
lin
Pra
ct E
ndoc
rinol
Met
ab 2
(4)
: 200
–10.
6.K
harli
pJ;
Sal
vato
riR
; Yen
okya
nG
; Wan
dG
S. R
ecur
renc
e of
hyp
erpr
olac
tinem
ia a
fter
with
draw
al o
f lo
ng-t
erm
cab
ergo
line
ther
apy.
J C
lin E
ndoc
rinol
Met
ab.
2009
; 94(
7):2
428-
367.
US
Foo
d an
d D
rug
Adm
inis
trat
ion.
"F
DA
app
rove
s H
umat
rope
for
shor
t sta
ture
" 20
03-0
7-25
8. "
Hum
an G
row
th H
orm
one
Def
icie
ncy"
. HG
H. R
etrie
ved
20 J
anua
ry 2
012.
9.S
andr
et L
, et a
l. "P
lace
of C
aber
golin
e in
Acr
omeg
aly:
A M
eta-
Ana
lysi
s". J
Clin
End
ocrin
ol M
etabb
. F
eb 1
6 20
1110
. Sch
war
tz's
Prin
cipl
es o
f Sur
gery
, 8th
Edi
tion,
p.1
455
11..."
Cus
hing
Syn
drom
e at
the
Nat
iona
l End
ocrin
e an
d M
etab
olic
Dis
ease
Info
rmat
ion
Ser
vice
." J
of
Am
eric
an M
edic
ineeee.
200
5;11
8(12
):13
40-1
346.
12. K
umar
, Abb
as, F
aust
o. R
obbi
ns a
nd C
otra
n P
atho
logi
c B
asis
of D
isea
see, 7
th E
ditio
n. E
lsev
ier-
Sau
nder
s; N
ew Y
ork,
200
513
. Fom
ekon
gE
, et a
l. O
utco
me
of tr
anss
phen
oida
l sur
gery
for
Cus
hing
's d
isea
se: a
hig
h re
mis
sion
ra
te in
AC
TH
-sec
retin
g m
acro
aden
omas
. Clin
Neu
rol N
euro
surg
ery.
200
9; 1
11(5
):44
2-9